Metals in Therapy and Diagnosis
Metals in Therapy and Diagnosis

Research Group Gimeno ‒ Universidad de Zaragoza/ ISQCH

María Concepción Gimeno Floría

Team leader

 

Our research interests focus on the design of luminescent and bioactive novel metallic complexes in order to develop new biological sensors and biomarkers, as well as the next generation of metallodrugs. The research is mainly divided in the following working lines:

1) Development of biologically active metallic species, mainly with group 11 metal complexes and using different types of ligands.
2) Design of gold-based peptidomimetics for selective drug delivery at tumor target sites.
3) Development of light-emissive complexes for bioimaging applications.
4) Design of theranostic metallic agents, including d6, d8 and d10 metal complexes and lanthanides complexes.
5) Bioactive silver and gold nanoparticles.

Our groups carries out the evaluation of the cytotoxic, antibacterial or anti-VIH activity of metallic compounds, together with the study of the mechanism of cellular death and cellular uptake and biodistribution.

 

Research group members:

Vanesa Fernández Moreira, María Dolores Villacampa Pérez, María Lourdes Ortego Cañaveras

Do you want to Support MetDrugs Research by Making a Donation?

You can contact us at:

info@metdrugs-network.com

News

7 March 2017: Conchita Gimeno is one of the awardees of the IUPAC 2017 Distinguished Women in Chemistry

 

20 October 2016: Second MetDrugs meeting

 

2 February 2016: First MetDrugs meeting

 

14 october 2015: The Ministry of Economy and Competitiveness of Spain finances the network

Ref: CTQ2015-70371-REDT

Follow us in

Versión para imprimir Versión para imprimir | Mapa del sitio
© Universitat de Barcelona